We are live on ! Find out more
EBS icon

Emergent Biosolutions
EBS

172 hedge funds and large institutions have $875M invested in Emergent Biosolutions in 2015 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 76 increasing their positions, 55 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more call options, than puts

Call options by funds: $325K | Put options by funds: $190K

43% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 14

38% more repeat investments, than reductions

Existing positions increased: 76 | Existing positions reduced: 55

7% more capital invested

Capital invested by funds: $818M → $875M (+$57.1M)

3% more funds holding

Funds holding: 167 → 172 (+5)

0.34% more ownership

Funds ownership: 80.44% → 80.77% (+0.34%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
172
Holders Change
+5
Holders Change %
+2.99%
% of All Funds
4.58%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
20
Increased
76
Reduced
55
Closed
14
Calls
$325K
Puts
$190K
Net Calls
+$135K
Net Calls Change
+$130K

Top Buyers

Rank Fund Capital Flow
1
NI
Numeric Investors
Massachusetts
+$8.66M
2
State Street
State Street
Massachusetts
+$8M
3
Millennium Management
Millennium Management
New York
+$5.47M
4
CPIM
Columbia Partners Investment Management
Virginia
+$3.18M
5
BFA
BlackRock Fund Advisors
California
+$2.84M

Top Sellers

Rank Fund Capital Flow
1
KCM
Kingdon Capital Management
New York
-$7.51M
2
BC
Broadfin Capital
New York
-$7.35M
3
IA
Icon Advisers
Colorado
-$6.23M
4
SBH
Segall Bryant & Hamill
Illinois
-$5.69M
5
GPP
Great Point Partners
Connecticut
-$4.22M
Name Holding Trade Value Shares
Change 		Change in
Stake
AQR Capital Management
26
AQR Capital Management
Connecticut
$8.22M +$496K +17,302 +6%
EAM
27
Eagle Asset Management
Florida
$8.17M +$211K +7,364 +3%
Goldman Sachs
28
Goldman Sachs
New York
$7.02M -$455K -15,847 -6%
Ameriprise
29
Ameriprise
Minnesota
$6.83M -$1.62M -56,603 -19%
Arrowstreet Capital
30
Arrowstreet Capital
Massachusetts
$6.67M -$661K -23,031 -9%
SO
31
STRS Ohio
Ohio
$6.41M -$22.9K -800 -0.4%
Millennium Management
32
Millennium Management
New York
$6.05M +$5.47M +190,857 +972%
KCM
33
Kingdon Capital Management
New York
$5.99M -$7.51M -261,703 -56%
Geode Capital Management
34
Geode Capital Management
Massachusetts
$5.59M +$260K +9,056 +5%
Principal Financial Group
35
Principal Financial Group
Iowa
$5.27M +$167K +5,837 +3%
Axa
36
Axa
France
$5.26M +$452K +15,744 +9%
American Century Companies
37
American Century Companies
Missouri
$5.01M -$516K -18,007 -9%
SCP
38
Seizert Capital Partners
Michigan
$4.68M -$2.17M -75,590 -32%
AAM
39
Aberdeen Asset Management
United Kingdom
$4.65M +$743K +25,900 +19%
MOACM
40
Mutual of America Capital Management
New York
$4.59M -$132K -4,599 -3%
TC
41
TFS Capital
Pennsylvania
$4.29M +$458K +15,963 +12%
PPA
42
Parametric Portfolio Associates
Washington
$4.2M +$353K +12,308 +9%
SBH
43
Segall Bryant & Hamill
Illinois
$4.16M -$5.69M -198,444 -58%
Two Sigma Advisers
44
Two Sigma Advisers
New York
$4.07M +$1.07M +37,200 +36%
RFC
45
Russell Frank Company
Washington
$4.02M -$1.37M -47,744 -25%
NAP
46
New Amsterdam Partners
New York
$3.92M -$1.08M -37,787 -22%
CRC
47
Curi RMB Capital
Illinois
$3.87M -$897K -31,271 -19%
Two Sigma Investments
48
Two Sigma Investments
New York
$3.76M +$1.31M +45,742 +54%
GCP
49
GSA Capital Partners
United Kingdom
$3.72M +$755K +26,311 +26%
Citadel Advisors
50
Citadel Advisors
Florida
$3.6M +$1.62M +56,312 +82%
1
2
3 4 5

EBS Hedge Fund Activity: Q1 2015 in Review

172 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Emergent Biosolutions (EBS) for Q1 2015, worth a combined $875M — up 7% from $818M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new EBS positions and 14 closed out — a net gain of 6 holders — while 76 added to existing stakes and 55 trimmed.

The largest buyer was Numeric Investors, opening a new position worth an estimated $8.66M. The largest seller was Kingdon Capital Management, cutting an estimated $7.51M.

  • 172 institutional investors held Emergent Biosolutions (EBS) as of Q1 2015, up from 167 in Q4 2014.
  • Funds reported $875M of Emergent Biosolutions stock for Q1 2015, up 7% quarter-over-quarter.
  • 20 funds opened new Emergent Biosolutions positions in Q1 2015 and 14 closed out, a net change of +6 holders.
  • The largest Emergent Biosolutions buyer in Q1 2015 was Numeric Investors, an estimated $8.66M added.
  • The largest Emergent Biosolutions seller in Q1 2015 was Kingdon Capital Management, an estimated $7.51M sold.

Based on aggregated 13F filings for Q1 2015.